1. Home
  2. JAZZ
  3. JAZZ News

Latest Jazz Pharmaceuticals plc (Ireland) (JAZZ) News on April 19, 2025

JAZZ vs. ARGX: Which Stock Is the Better Value Option?
JAZZ

Zacks

2 days ago

JAZZ vs. ARGX: Which Stock Is the Better Value Option?

Why Jazz Pharmaceuticals (JAZZ) is a Top Value Stock for the Long-Term
JAZZ

Zacks

2 days ago

Why Jazz Pharmaceuticals (JAZZ) is a Top Value Stock for the Long-Term

Is Jazz Pharmaceuticals a Top Cannabis Investment for 2025?
JAZZ

Zacks

2 days ago

Is Jazz Pharmaceuticals a Top Cannabis Investment for 2025?

Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers
JAZZ

StockStory

2 days ago

Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers

JAZZ

Argus Research

4 days ago

JAZZ: What does Argus have to say about JAZZ?

Jazz (JAZZ) Moves 7.1% Higher: Will This Strength Last?
JAZZ

Zacks

9 days ago

Jazz (JAZZ) Moves 7.1% Higher: Will This Strength Last?

JAZZ Pharmaceuticals Stock Trades Near 52-Week Low: Time to Buy or Sell?
JAZZ

Zacks

10 days ago

JAZZ Pharmaceuticals Stock Trades Near 52-Week Low: Time to Buy or Sell?

JAZZ

Argus Research

11 days ago

JAZZ: Lowering target price to $113.00

JAZZ

Morningstar Research

11 days ago

Analyst Report: Jazz Pharmaceuticals plc

5 High ROE Stocks to Buy as Markets Face Tariff Bloodbath
JAZZ

Zacks

12 days ago

5 High ROE Stocks to Buy as Markets Face Tariff Bloodbath

JAZZ

MT Newswires

16 days ago

RBC Raises Price Target on Jazz Pharmaceuticals to $182 From $178, Keeps Outperform Rating

JAZZ

Argus Research

18 days ago

JAZZ: Lowering target price to $137.00

After a year of 4.3% returns, Jazz Pharmaceuticals plc's (NASDAQ:JAZZ) share price drop last week may have less of an impact on institutional investors
JAZZ

Simply Wall St.

18 days ago

After a year of 4.3% returns, Jazz Pharmaceuticals plc's (NASDAQ:JAZZ) share price drop last week may have less of an impact on institutional investors

JAZZ or ARGX: Which Is the Better Value Stock Right Now?
JAZZ

Zacks

19 days ago

JAZZ or ARGX: Which Is the Better Value Stock Right Now?

Is Jazz Pharmaceuticals (JAZZ) the Best Mid Cap Biotech Stock to Buy?
JAZZ

Insider Monkey

21 days ago

Is Jazz Pharmaceuticals (JAZZ) the Best Mid Cap Biotech Stock to Buy?

Jazz (JAZZ) Down 9.2% Since Last Earnings Report: Can It Rebound?
JAZZ

Zacks

23 days ago

Jazz (JAZZ) Down 9.2% Since Last Earnings Report: Can It Rebound?

Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference
JAZZ

PR Newswire

24 days ago

Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference

Is Jazz Pharmaceuticals plc (JAZZ) a Promising Biotech Stock According to Wall Street Analysts
JAZZ

Insider Monkey

25 days ago

Is Jazz Pharmaceuticals plc (JAZZ) a Promising Biotech Stock According to Wall Street Analysts

Why Jazz Pharmaceuticals (JAZZ) is a Top Momentum Stock for the Long-Term
JAZZ

Zacks

a month ago

Why Jazz Pharmaceuticals (JAZZ) is a Top Momentum Stock for the Long-Term

Zacks.com featured highlights include MPLX LP, Leidos, Jazz Pharmaceuticals, Fortinet and Pilgrim's Pride
JAZZ

Zacks

a month ago

Zacks.com featured highlights include MPLX LP, Leidos, Jazz Pharmaceuticals, Fortinet and Pilgrim's Pride

TPB, ACB and JAZZ: Three Pot Stocks Flowering With Potential Upside
JAZZ

TipRanks

a month ago

TPB, ACB and JAZZ: Three Pot Stocks Flowering With Potential Upside

5 High ROE Stocks to Buy as Markets Dip Despite Rate Cut Hopes
JAZZ

Zacks

a month ago

5 High ROE Stocks to Buy as Markets Dip Despite Rate Cut Hopes

Does Jazz (JAZZ) Have the Potential to Rally 38.94% as Wall Street Analysts Expect?
JAZZ

Zacks

a month ago

Does Jazz (JAZZ) Have the Potential to Rally 38.94% as Wall Street Analysts Expect?

3 Value Stocks Skating on Thin Ice
JAZZ

StockStory

a month ago

3 Value Stocks Skating on Thin Ice

Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Epidiolex® (cannabidiol) at American Academy of Neurology Annual Meeting
JAZZ

PR Newswire

a month ago

Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Epidiolex® (cannabidiol) at American Academy of Neurology Annual Meeting

Cash In On The Luck Of The Irish With 5 St. Patrick's Day Stocks Near Buy Points
JAZZ

Investor's Business Daily

a month ago

Cash In On The Luck Of The Irish With 5 St. Patrick's Day Stocks Near Buy Points

JAZZ or ILMN: Which Is the Better Value Stock Right Now?
JAZZ

Zacks

a month ago

JAZZ or ILMN: Which Is the Better Value Stock Right Now?

Will Auvelity & Other Drugs Aid AXSM's Growth Amid Stiff Competition?
JAZZ

Zacks

a month ago

Will Auvelity & Other Drugs Aid AXSM's Growth Amid Stiff Competition?

Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Value Stock
JAZZ

Zacks

a month ago

Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Value Stock

JAZZ

MT Newswires

a month ago

Jazz Pharmaceuticals Insider Sold Shares Worth $332,605, According to a Recent SEC Filing

BIIB Starts Felzartamab Phase III Study in AMR in Kidney Transplant
JAZZ

Zacks

a month ago

BIIB Starts Felzartamab Phase III Study in AMR in Kidney Transplant

Jazz Pharmaceuticals and Boston Beer Company have been highlighted as Zacks Bull and Bear of the Day
JAZZ

Zacks

a month ago

Jazz Pharmaceuticals and Boston Beer Company have been highlighted as Zacks Bull and Bear of the Day

Bull of the Day: Jazz Pharmaceuticals (JAZZ)
JAZZ

Zacks

a month ago

Bull of the Day: Jazz Pharmaceuticals (JAZZ)

4 Discounted PEG Stocks Offering the Best Returns to Value Investors
JAZZ

Zacks

a month ago

4 Discounted PEG Stocks Offering the Best Returns to Value Investors

Why Chimerix, Inc. (CMRX) Soared Last Week
JAZZ

Insider Monkey

a month ago

Why Chimerix, Inc. (CMRX) Soared Last Week

The Zacks Analyst Blog Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals
JAZZ

Zacks

a month ago

The Zacks Analyst Blog Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals

Biotech Stocks Roundup: CMRX Up on JAZZ Bid, MRNA Up on Updates & More
JAZZ

Zacks

a month ago

Biotech Stocks Roundup: CMRX Up on JAZZ Bid, MRNA Up on Updates & More

JAZZ

MT Newswires

a month ago

Update: Truist Raises PT on Jazz Pharmaceuticals to $230 From $220 on Heels of Announced Purchase of Chimerix, Keeps Buy Rating

Jazz Offers to Buy Chimerix for $935M to Boost Oncology Portfolio
JAZZ

Zacks

a month ago

Jazz Offers to Buy Chimerix for $935M to Boost Oncology Portfolio

Beat Market Volatility With 4 Low-Beta Stocks: PGR, PSO, TXO & JAZZ
JAZZ

Zacks

a month ago

Beat Market Volatility With 4 Low-Beta Stocks: PGR, PSO, TXO & JAZZ

JAZZ

MT Newswires

a month ago

Truist Raises Price Target on Jazz Pharmaceuticals to $230 From $220, Keeps Buy Rating

3 Highly Ranked Medical Stocks to Buy Amid Recent Market Volatility: JAZZ, OPCH, PCRX,
JAZZ

Zacks

a month ago

3 Highly Ranked Medical Stocks to Buy Amid Recent Market Volatility: JAZZ, OPCH, PCRX,

Jazz Pharmaceuticals bids for Chimerix in $935m deal
JAZZ

Pharmaceutical Technology

a month ago

Jazz Pharmaceuticals bids for Chimerix in $935m deal

JAZZ

MT Newswires

a month ago

Chimerix a Prime Acquisition Candidate for Jazz Pharmaceuticals Due to Dordaviprone, Wedbush Says

Gilead Sciences, Inc. (GILD) Hits Fresh High: Is There Still Room to Run?
JAZZ

Zacks

a month ago

Gilead Sciences, Inc. (GILD) Hits Fresh High: Is There Still Room to Run?

JAZZ

MT Newswires

a month ago

Jazz Pharmaceuticals to Acquire Chimerix in $935 Million Deal

Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
JAZZ

PR Newswire

a month ago

Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio

Jazz expands in oncology with $935M deal for Chimerix
JAZZ

BioPharma Dive

a month ago

Jazz expands in oncology with $935M deal for Chimerix

Statutory Profit Doesn't Reflect How Good Jazz Pharmaceuticals' (NASDAQ:JAZZ) Earnings Are
JAZZ

Simply Wall St.

a month ago

Statutory Profit Doesn't Reflect How Good Jazz Pharmaceuticals' (NASDAQ:JAZZ) Earnings Are

Zacks.com featured highlights include EverQuote, Jazz Pharmaceuticals, The Progressive, Sony and NatWest
JAZZ

Zacks

a month ago

Zacks.com featured highlights include EverQuote, Jazz Pharmaceuticals, The Progressive, Sony and NatWest

3 Small-Cap Stocks Skating on Thin Ice
JAZZ

StockStory

2 months ago

3 Small-Cap Stocks Skating on Thin Ice

Jazz Pharmaceuticals plc (JAZZ): Among the Cash-Rich Mid Cap Stocks to Buy Now
JAZZ

Insider Monkey

2 months ago

Jazz Pharmaceuticals plc (JAZZ): Among the Cash-Rich Mid Cap Stocks to Buy Now

Earnings Estimates Moving Higher for Jazz (JAZZ): Time to Buy?
JAZZ

Zacks

2 months ago

Earnings Estimates Moving Higher for Jazz (JAZZ): Time to Buy?

Wall Street Analysts See a 29.63% Upside in Jazz (JAZZ): Can the Stock Really Move This High?
JAZZ

Zacks

2 months ago

Wall Street Analysts See a 29.63% Upside in Jazz (JAZZ): Can the Stock Really Move This High?

4 Stocks Trading Near 52-Week High With More Upside Potential
JAZZ

Zacks

2 months ago

4 Stocks Trading Near 52-Week High With More Upside Potential

Jazz Pharmaceuticals (JAZZ) is a Top-Ranked Growth Stock: Should You Buy?
JAZZ

Zacks

2 months ago

Jazz Pharmaceuticals (JAZZ) is a Top-Ranked Growth Stock: Should You Buy?

International Markets and Jazz (JAZZ): A Deep Dive for Investors
JAZZ

Zacks

2 months ago

International Markets and Jazz (JAZZ): A Deep Dive for Investors

Jazz Pharmaceuticals plc Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
JAZZ

Simply Wall St.

2 months ago

Jazz Pharmaceuticals plc Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

JAZZ

Morningstar Research

2 months ago

Analyst Report: Jazz Pharmaceuticals plc

Why Jazz Pharmaceuticals (JAZZ) is a Top Value Stock for the Long-Term
JAZZ

Zacks

2 months ago

Why Jazz Pharmaceuticals (JAZZ) is a Top Value Stock for the Long-Term

JAZZ

MT Newswires

2 months ago

RBC Trims Price Target on Jazz Pharmaceuticals to $178 From $179, Keeps Outperform Rating

Despite the downward trend in earnings at Jazz Pharmaceuticals (NASDAQ:JAZZ) the stock advances 3.2%, bringing five-year gains to 21%
JAZZ

Simply Wall St.

2 months ago

Despite the downward trend in earnings at Jazz Pharmaceuticals (NASDAQ:JAZZ) the stock advances 3.2%, bringing five-year gains to 21%

Jazz Pharmaceuticals PLC (JAZZ) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...
JAZZ

GuruFocus.com

2 months ago

Jazz Pharmaceuticals PLC (JAZZ) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...

JAZZ

Argus Research

2 months ago

JAZZ: Raising target price to $154.00

Compared to Estimates, Jazz (JAZZ) Q4 Earnings: A Look at Key Metrics
JAZZ

Zacks

2 months ago

Compared to Estimates, Jazz (JAZZ) Q4 Earnings: A Look at Key Metrics

Jazz Pharmaceuticals (JAZZ) Tops Q4 Earnings and Revenue Estimates
JAZZ

Zacks

2 months ago

Jazz Pharmaceuticals (JAZZ) Tops Q4 Earnings and Revenue Estimates

Jazz Pharmaceuticals (NASDAQ:JAZZ) Surprises With Q4 Sales
JAZZ

StockStory

2 months ago

Jazz Pharmaceuticals (NASDAQ:JAZZ) Surprises With Q4 Sales

JAZZ

MT Newswires

2 months ago

Jazz Pharmaceuticals Q4 Non-GAAP Earnings, Revenue Rise; 2025 Guidance Issued

JAZZ

Associated Press Finance

2 months ago

Jazz: Q4 Earnings Snapshot

Jazz Pharmaceuticals (JAZZ) Reports Earnings Tomorrow: What To Expect
JAZZ

StockStory

2 months ago

Jazz Pharmaceuticals (JAZZ) Reports Earnings Tomorrow: What To Expect

Jazz Pharmaceuticals to Participate in TD Cowen's 45th Annual Health Care Conference
JAZZ

PR Newswire

2 months ago

Jazz Pharmaceuticals to Participate in TD Cowen's 45th Annual Health Care Conference

Jazz (JAZZ) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
JAZZ

Zacks

2 months ago

Jazz (JAZZ) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

JAZZ

Argus Research

2 months ago

JAZZ: Raising target price to $149.00

Jazz (JAZZ) Surges 5.2%: Is This an Indication of Further Gains?
JAZZ

Zacks

2 months ago

Jazz (JAZZ) Surges 5.2%: Is This an Indication of Further Gains?

Jazz Pharmaceuticals to Report 2024 Full Year and Fourth Quarter Financial Results on February 25, 2025
JAZZ

PR Newswire

2 months ago

Jazz Pharmaceuticals to Report 2024 Full Year and Fourth Quarter Financial Results on February 25, 2025

Why Jazz (JAZZ) is Poised to Beat Earnings Estimates Again
JAZZ

Zacks

2 months ago

Why Jazz (JAZZ) is Poised to Beat Earnings Estimates Again

JAZZ

Argus Research

2 months ago

JAZZ: Lowering target price to $134.00

JAZZ

Argus Research

3 months ago

JAZZ: Raising target price to $136.00

JAZZ

Argus Research

3 months ago

JAZZ: Lowering target price to $133.00

JP Morgan 2025: Jazz Pharmaceuticals focusing on oncology pipeline
JAZZ

Clinical Trials Arena

3 months ago

JP Morgan 2025: Jazz Pharmaceuticals focusing on oncology pipeline

Jazz Pharmaceuticals plc (JAZZ): Analysts Recommend This 52-Week High Stocks Now
JAZZ

Insider Monkey

3 months ago

Jazz Pharmaceuticals plc (JAZZ): Analysts Recommend This 52-Week High Stocks Now

JAZZ

Argus Research

3 months ago

JAZZ: What does Argus have to say about JAZZ?

JAZZ

Argus Research

4 months ago

JAZZ: Raising target price to $137.00

JAZZ

Argus Research

4 months ago

JAZZ: Raising target price to $135.00

Jazz Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
JAZZ

PR Newswire

4 months ago

Jazz Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

JAZZ

MT Newswires

4 months ago

Jazz Pharmaceuticals CEO Bruce Cozadd Plans to Retire

Jazz Pharmaceuticals Announces CEO Succession Plan
JAZZ

PR Newswire

4 months ago

Jazz Pharmaceuticals Announces CEO Succession Plan

JAZZ

MT Newswires

4 months ago

Truist Securities Adjusts Jazz Pharmaceuticals Public Price Target to $220 From $200, Maintains Buy Rating

Is Now The Time To Put Jazz Pharmaceuticals (NASDAQ:JAZZ) On Your Watchlist?
JAZZ

Simply Wall St.

4 months ago

Is Now The Time To Put Jazz Pharmaceuticals (NASDAQ:JAZZ) On Your Watchlist?

Jazz upgraded to Overweight at Morgan Stanley after Ziihera launch
JAZZ

TipRanks

4 months ago

Jazz upgraded to Overweight at Morgan Stanley after Ziihera launch

5 High ROE Stocks to Buy as Volatility Weighs on Markets
JAZZ

Zacks

4 months ago

5 High ROE Stocks to Buy as Volatility Weighs on Markets

JAZZ

Argus Research

4 months ago

JAZZ: Lowering target price to $132.00

JAZZ

MT Newswires

4 months ago

Jazz Pharmaceuticals Likely to Launch FDA-Approved Biliary Tract Cancer Treatment in 2025, RBC Says

Jazz Pharmaceuticals to Showcase New Real-World Evidence Reinforcing Epidiolex® (cannabidiol) Benefits and Broad-Spectrum Efficacy in Treatment-Resistant Epilepsies at the American Epilepsy Society 2024 Annual Meeting
JAZZ

PR Newswire

4 months ago

Jazz Pharmaceuticals to Showcase New Real-World Evidence Reinforcing Epidiolex® (cannabidiol) Benefits and Broad-Spectrum Efficacy in Treatment-Resistant Epilepsies at the American Epilepsy Society 2024 Annual Meeting

Jazz (JAZZ) Up 3.4% Since Last Earnings Report: Can It Continue?
JAZZ

Zacks

4 months ago

Jazz (JAZZ) Up 3.4% Since Last Earnings Report: Can It Continue?

Jazz Pharmaceuticals Announces Update to National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for Biliary Tract Cancers to Include zanidatamab-hrii (Ziihera®)
JAZZ

PR Newswire

4 months ago

Jazz Pharmaceuticals Announces Update to National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for Biliary Tract Cancers to Include zanidatamab-hrii (Ziihera®)

Jazz Pharmaceuticals Announces Ziihera® (zanidatamab-hrii) Investor Webcast on December 11, 2024
JAZZ

PR Newswire

4 months ago

Jazz Pharmaceuticals Announces Ziihera® (zanidatamab-hrii) Investor Webcast on December 11, 2024

JAZZ

Argus Research

5 months ago

JAZZ: Lowering target price to $134.00

Jazz Pharmaceuticals to Present Advancements in Solid Tumors and Blood Cancer Research at San Antonio Breast Cancer Symposium and American Society of Hematology Annual Meeting
JAZZ

PR Newswire

5 months ago

Jazz Pharmaceuticals to Present Advancements in Solid Tumors and Blood Cancer Research at San Antonio Breast Cancer Symposium and American Society of Hematology Annual Meeting

Wall Street Analysts Think Jazz (JAZZ) Could Surge 44.37%: Read This Before Placing a Bet
JAZZ

Zacks

5 months ago

Wall Street Analysts Think Jazz (JAZZ) Could Surge 44.37%: Read This Before Placing a Bet

Share on Social Networks: